-
Although PPIs are considered to be among the safest of drugs, these studies suggest that PPIs increase the risk for hospitalized patients to develop C. difficile-related diarrhea.
-
FDA has approved a 5-nitroimidazole for the treatment of trichomoniasis, giardiasis, and amebiasis. Tinidazole, a second-generation nitroimidazole antiprotozoal agent, is marketed as TindamaxTM by Presutti Laboratories.
-
Multivitamin Supplements and HIV Disease Progression and Mortality; The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study; Trial of Atorvastatin in Rheumatoid Arthritis (TARA)
-
The ECG in the Figure was interpreted as showing PVCs (premature ventricular contractions) and chamber enlargement. Do you agree? Can you identify at least four findings keyed by the P in this ECG?
-
Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published.
-
-
A quick review of your clinics dispensing habits tells the tale: More women are moving to use of the transdermal contraceptive. The contraceptive patch is now the favorite nonoral contraceptive method in the United States, according to IMS Health, a Fairfield, CT-based supplier of pharmaceutical industry market research.
-
An e-pharmacy may be suspect if it does the following.
-
Current understanding of female reproductive biology may be revised with publication of new research that indicates that female mice retain the ability to make new egg cells well into adulthood.
-
Early summer should see the publication of a detailed analysis from the estrogen-alone arm of the Womens Health Initiative (WHI). The study was suspended in February when scientists determined the therapy did not appear to affect heart disease, the major question being evaluated in the trial.